NFKB1 and mantle cell lymphoma: Additionally, Supplementary Figure 1 illustrates the reduction of p100 levels in the context of CD40L treatment and additional inhibition of the classical pathway, underlining the activating role of CD40L on alternative NFκB signaling in MCL cells.